ABSTRACT
Extracorporeal membrane oxygenation (ECMO) is a well-established treatment for cardiorespiratory failure in the neonatal and paediatric population. The majority of pediatric patients supported with ECMO have isolated respiratory failure secondary to pneumonia and acute lung injury and can be supported by venovenous ECMO.
